"Thun and colleagues at the cancer society wondered if many of those earlier studies used too low a dose of aspirin to have an anticancer effect. So they examined adult-strength aspirin — 325 mg or more — in a study tracking more than 140,000 people.Taking an adult-strength aspirin daily for at least five years was associated with a 30 percent lower risk of colorectal cancer, a 20 percent lower risk of prostate cancer, and 15 percent less cancer overall, they reported last week in the Journal of the "Taking an adult-strength aspirin daily for at least five years was associated with a 30 percent lower risk of colorectal cancer, a 20 percent lower risk of prostate cancer, and 15 percent less cancer overall, they reported last week in the Journal of the National Cancer Institute."
That's not proof of aspirin's benefit, either, but it does suggest that clinical trials start looking at higher doses to tease out an answer."
Interesting without any real answers...Stay tuned!
Posts
No comments:
Post a Comment